Feature Channels: Vaccines

Filters close
Released: 7-Feb-2020 9:45 AM EST
Pneumococcal Vaccines Are Effective – But New Strategies Needed to Reduce Meningitis
Wolters Kluwer Health: Lippincott

Pneumococcal conjugate vaccines (PCVs) have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria. But rates of meningitis have shown little change, as pneumococcal strains not targeted by PCVs emerge as more important causes of meningitis, reports a paper in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 6-Feb-2020 6:00 AM EST
New Tool Monitors Real Time Mutations In Flu
Rutgers University-New Brunswick

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.

   
Released: 4-Feb-2020 11:05 AM EST
Vanderbilt-Ingram Cancer Center Patient First for New Cell Engineering Platform
Vanderbilt University Medical Center

VICC is the first cancer center to enroll a patient in a clinical trial for this new technology developed by SQZ Biotechnologies of Watertown, Massachusetts. The investigational product is generated from the company’s technology that uses high-speed cell deformation to squeeze cells, creating a temporary disruption of their membranes and offering a window for the insertion of tumor antigens.

Released: 3-Feb-2020 1:50 PM EST
Gauging the threat posed by the coronavirus
University of Georgia

Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia’s College of Public Health.

29-Jan-2020 4:55 PM EST
Exposing a virus’s hiding place reveals new potential vaccine
Ohio State University

By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.

   
Released: 3-Feb-2020 9:45 AM EST
Women’s Heart Fund Launches ‘Community Conversations with the CDI’
Hackensack Meridian Health

The Women’s Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor ‘Community Conversations with the CDI,’ a women-focused, three-year lecture series featuring researchers from Hackensack Meridian Health’s Center for Discovery and Innovation (CDI). The lectures will focus on topics relevant to community members throughout the state, including heart disease, breast and ovarian cancer, vaccines, Alzheimer’s Disease and diabetes.

Released: 31-Jan-2020 12:40 PM EST
Scientists develop safer, less costly polio vaccine
Uniformed Services University of the Health Sciences (USU)

As the world nears poliovirus eradication, the vaccines themselves have become the greatest threat. In response to a global demand for an effective, safer-to-handle and less costly polio vaccine, scientists at the Uniformed Services University (USU) have developed a new one that could help secure a polio-free world.

Released: 29-Jan-2020 5:00 PM EST
Infectious Disease Experts Sound Alarm Over Risk of Outbreaks in U.S. Border Detention Centers
University of Maryland School of Medicine

– Over the past year, at least seven children have died from diseases including influenza while being detained by the U.S. Department of Homeland Security’s Customs and Border Protection (CBP) agency. Infectious disease experts at the University of Maryland School of Medicine (UMSOM) called for protections like influenza vaccinations to prevent serious outbreaks.

Released: 28-Jan-2020 10:15 AM EST
The HPV vaccine: What parents need to know
University of Chicago Medical Center

The HPV vaccine protects against some of the deadliest, most disfiguring and hard-to-treat cancers. Here is what parents of teens and pre-teens should know about the HPV vaccine.

Released: 23-Jan-2020 11:45 AM EST
Wuhan coronavirus: An infectious disease expert explains we know so far about the new virus emerging in Asia
University of Chicago Medical Center

University of Chicago Medicine associate professor and infectious disease expert Dr. Emily Landon explains what public health officials know about new coronavirus virus from Wuhan, China and how to stay safe.

22-Jan-2020 8:00 AM EST
Study results will inform immunization programs globally
University of Adelaide

The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine.

Released: 22-Jan-2020 9:00 AM EST
Full influenza vaccination among children cuts hospitalization in half
University of Michigan

Fully vaccinating children reduces the risk of hospitalization associated with influenza by 54%, according to a study by researchers at the University of Michigan, the Clalit Research Institute, and Ben-Gurion University in Israel.

Released: 21-Jan-2020 2:20 PM EST
Why Experts Are Worried About a New Virus in China
Council on Foreign Relations (CFR)

The virus appears to be less dangerous than SARS, but there are still concerns of a wider outbreak in Asia.

14-Jan-2020 3:35 PM EST
Zika Virus’ Key into Brain Cells ID’d, Leveraged to Block Infection and Kill Cancer Cells
UC San Diego Health

Two different UC San Diego research teams identified the same molecule — αvβ5 integrin — as Zika virus’ key to brain cell entry. They found ways to take advantage of the integrin to both block Zika virus from infecting cells and turn it into something good: a way to shrink brain cancer stem cells.

Released: 15-Jan-2020 8:05 AM EST
The Truth About the HPV Vaccine: 7 Myths and Facts You Need to Know
Nuvance Health

A vaccine is available to protect against human papillomavirus (HPV). HPV is the most common sexually transmitted infection and can cause diseases such as genital warts and cancer. The HPV vaccine now protects against nine strains of HPV. Research shows that the HPV vaccine is safe and effective. The HPV vaccine is approved for men and women between the ages of 9 to 45. The HPV vaccine can protect adults from HPV-related diseases, however it provides the most protection when it is given in childhood before someone becomes sexually active. Parents should talk with their child’s pediatrician about the HPV vaccine. Adult men should ask their primary care provider about the HPV vaccine, and adult women should speak with their gynecologist.

Released: 13-Jan-2020 5:30 PM EST
Everything You Need to Know About the Flu
Beth Israel Lahey Health

Sharon Wright,MD, MPH, BIDMC’s Senior Medical Director of Infection Control/Hospital Epidemiology at Beth Israel Deaconess Medical Center shares everything you need to know about the flu.

Released: 9-Jan-2020 3:05 PM EST
Inside Pediatrics Podcast: Flu Season Tips for Kids
Children's of Alabama

Dr. Kathy Monroe has seen her share of the flu in Alabama's busiest emergency department for kids. She shares important tips on who should get the flu vaccine, when to get it, and what to do when your child shows signs and symptoms.

Released: 9-Jan-2020 1:35 PM EST
Study finds salt nanoparticles are toxic to cancer cells
University of Georgia

A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient.

   
Released: 9-Jan-2020 12:25 PM EST
Less Severe Cases of Diarrheal Illness Can Still Lead to Child Deaths, Research Shows
University of Maryland School of Medicine

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age. Now, researchers at the University of Maryland School of Medicine (UMSOM) found that even milder cases of diarrheal diseases can lead to death in young children.

Released: 8-Jan-2020 4:10 PM EST
Penn Study Paves Way for New Vaccines to Protect Infants Against Infections
Perelman School of Medicine at the University of Pennsylvania

A new Penn Medicine study puts researchers within closer reach of vaccines that can protect infants against infections by overcoming a mother’s antibodies, which are known to shut down immune defenses initiated by conventional vaccines. That hurdle largely explains why vaccinations for infectious diseases like influenza and measles not given until six to 12 months of age. Findings from the preclinical study were published online today in Science Translational Medicine.

6-Jan-2020 11:25 AM EST
A Mother’s Bugs
Harvard Medical School

-Newborn mice derive protective antibodies from their mothers’ microbiota -Antibodies derived from mothers’ microbiota ward off both localized and widespread systemic infections by the bacterium E. coli -Study points to the role of maternal microbes in offspring protection and neonatal immunity -Findings can inform development of microbe-based therapies against infectious diarrhea in infants

Released: 8-Jan-2020 12:05 PM EST
Virus surfaces help MTU engineers study vaccine and gene therapy applications
Michigan Technological University

An isoelectric point is a common way to characterize viruses. However, it’s not easy. To improve manufacturing for vaccines and gene therapy, a Michigan Tech team uses surface charge to determine the isoelectric point of different viruses. Specifically, they use a single-particle method with atomic force microscopy (AFM).

Released: 7-Jan-2020 2:15 PM EST
Weizmann Scientists Create Decoy Molecule that Neutralizes Arenaviruses
Weizmann Institute of Science

Weizmann Institute scientists created a decoy molecule that successfully recruits the immune system to fight arenaviruses. It also appears to be heat-resistant and stable, meaning it could be delivered to the remote areas where these diseases are endemic.

Released: 7-Jan-2020 10:00 AM EST
NYU Langone Health Launches Multi-faceted Vaccine Center
NYU Langone Health

Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies and public health outreach to prevent the spread of infectious diseases and other immunological disorders.

30-Dec-2019 11:20 AM EST
Delivering TB Vaccine Intravenously Dramatically Improves Potency, Study Shows
Health Sciences at the University of Pittsburgh

Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated. The vaccine just isn’t that reliable. But a new Nature study finds that simply changing the way the vaccine is administered could dramatically boost its protective power.

20-Dec-2019 1:10 PM EST
Women with single dose of HPV vaccine gain similar protection as multiple doses
University of Texas Health Science Center at Houston

A new study revealed that one dose of the HPV vaccine may prevent infection from the potential cancer-causing virus, according to research published in JAMA Network Open from The University of Texas Health Science Center at Houston (UTHealth).

20-Dec-2019 4:35 PM EST
Why isn’t there a vaccine for staph?
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis may help explain why previous attempts to develop a staph vaccine have failed, while also suggesting a new approach to vaccine design that focuses on activating an untapped set of immune cells, as well as immunizing against staph within the first few days after birth.

Released: 20-Dec-2019 12:05 PM EST
Why your first battle with flu matters most
University of Arizona

How successfully a person can fend off the flu depends not only on the virus' notorious ability to change with the season, but also on the strain first encountered during childhood, according to new research published in the open-access journal PLoS Pathogens.

19-Dec-2019 10:00 AM EST
Researchers Identify Potential Formula for Blood Cancer Vaccine
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.

Released: 17-Dec-2019 12:35 PM EST
When should a young girl visit a gynecologist?
University of Chicago Medical Center

According to the American College of Obstetricians and Gynecologist, girls should have their first gynecologic visit between the ages of 13 and 15. Here's what parents need to know about when to take teens to an adolescent gynecologist.

Released: 11-Dec-2019 8:15 AM EST
How sand fly mating habits are helping tackle tropical disease in £2.5M project
University of Warwick

The tropical disease Leishmaniasis is being tackled by catching female sand flies who carry the parasite that causes the disease

Released: 10-Dec-2019 3:40 PM EST
Umsom Researchers to Test Vaccine Designed to Protect Against Serious Illness From Contaminated Food and Water
University of Maryland School of Medicine

Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli (ETEC), and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.

Released: 10-Dec-2019 7:30 AM EST
Influenza IMPRINT Cohort Study Receives Funding Boost
Cincinnati Children's Hospital Medical Center

The Influenza IMPRINT Cohort study will explore the emerging idea that a person’s very first influenza virus exposure impacts the magnitude, durability and breadth of their immune response to all future flu exposures.

20-Nov-2019 3:15 PM EST
Natural Toxins in the Global Food Supply Continue to Threaten the Health of Underprivileged Communities
Society for Risk Analysis (SRA)

Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health effects,, is also linked to vaccine resistance, and for the first time the global burden of disease from foodborne arsenic, lead, cadmium, and methyl mercury has been quantified.. The Society for Risk Analysis (SRA) will present new studies as part of its Global Disease Burden Caused by Foodborne Chemicals and Toxins symposium on Monday, Dec. 9 from 1:30-3:00 p.m. as part of its 2019 Annual Meeting at the Crystal Gateway Marriott in Arlington, Virginia. This symposium will provide updates to a 2015 World Health Organization (WHO) publication which analyzed the disease burdens caused by these toxins.

Released: 9-Dec-2019 2:45 PM EST
Research at Argonne's Advanced Photon Source leads to new Ebola drug
Argonne National Laboratory

Scientists using specialized beamlines at Argonne's Structural Biology Center (SBC), a facility for macromolecular crystallography at the Advanced Photon Source, derived insights that led to the discovery of a promising new drug for Ebola.

   
5-Dec-2019 9:00 AM EST
Peanut Allergy Vaccine to Rewrite the Immune System
University of South Australia

Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that’s poised to cure the potentially life threatening condition.

   
Released: 4-Dec-2019 2:05 PM EST
Flu Preparedness Hearing Opens Opportunities for Vaccine, AMR Action
Infectious Diseases Society of America (IDSA)

Today’s subcommittee hearing on U.S. preparedness and responses for the 2019-2020 flu season offers an important opportunity to examine and act on gaps and challenges exacerbating the public health threats of seasonal influenza outbreaks.

Released: 3-Dec-2019 12:30 PM EST
Virtual Reality Could Help Flu Vaccination Rates
University of Georgia

Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu vaccination, according to a study by researchers at the University of Georgia and the Oak Ridge Associated Universities in Oak Ridge, Tennessee

Released: 26-Nov-2019 4:05 PM EST
Simulating amino acid starvation may improve dengue vaccines
Cornell University

In a new paper in Science Signaling, researchers at the University of Hyderabad in India and the Cornell University College of Veterinary Medicine show that a plant-based compound called halofuginone improves the immune response to a potential vaccine against dengue virus.

Released: 26-Nov-2019 11:55 AM EST
Building a betterflu shot
Michigan State University

Each year millions of Americans become sick with the flu, hundreds of thousands are hospitalized and tens of thousands die. Getting the flu shot can reduce the chances of infection. But, at best, the vaccine is only effective 40% to 60% of the time, according to the CDC. Now Michigan State University researchers have data that show how cellular RNA levels change following infection or vaccination.

26-Nov-2019 9:00 AM EST
HIV: Overwhelming the enemy from the start
Universite de Montreal

Virologist Eric Cohen and his team have identified a way to thwart HIV infection at its very early stages.



close
2.982